The IACM bulletin is the newsletter of the International Association for Cannabis as Medicine. It is distributed by e-mail on a bi-weekly basis. You may subscribe online here.
International Association for Cannabis as Medicine (IACM)
Am Mildenweg 6
International Association for Cannabis as Medicine
The International Association for Cannabis as Medicine (IACM) was founded in March 2000. It is a scientific society advocating the improvement of the legal situation for the use of the hemp plant (Cannabis sativa L.) and its pharmacologically most important active compounds, the cannabinoids, for therapeutic applications through promotion of research and dissemination of information. The IACM declares that it is the right of doctors to be able to discuss the medicinal use of cannabis with their patients.
Cannabis and the Cannabinoids
Cannabis preparations have been used as remedies for thousands of years. The active ingredients of the hemp plant can currently also be put to use in a multitude of severe medical conditions. However, the potential medical applications of natural cannabis products or individual pharmacologically active ingredients are considerably restricted by existing laws and decrees.
There are regular and associate members. Regular members elect the board of directors consisting of up to ten members and decide on the guidelines of the association. Associate members elect up to two patient representatives The patient representatives may participate with equal rights in the meetings of the Board of Directors. The complete statutory articles of the IACM can be downloaded here as a pdf file.
Members receive the newsletter of IACM (IACM-News). The IACM Bulletin is published in several languages on the internet. Free subscription with the online-form.
Members of one or several nations may found a regional section to deal with regional affairs. The divisions may elect their own representatives and choose their own regulations. In regional divisions all members may have equal rights and decide on the guidelines of the work, analogous to the ACM in the German language region. Existing national organisations may become a member of the IACM, if goals and principles are congruent.
Board of Directors
Members of the board of directors are:
Kirsten Müller-Vahl, Germany, 1st Chairwoman
Roger Pertwee, UK, 2nd Chairman
Franjo Grotenhermen, Germany, Executive Director
Rudolf Brenneisen, Switzerland
Ethan Russo, USA
Daniela Parolaro, Italy
William Notcutt, UK
Kurt Blaas, Austria
Mark Ware, Canada
Marta Duran, Spain
The Patient Representative is:
Clare Hodges, UK, Alliance for Cannabis Therapeutics
Former Chairmen of the IACM
Franjo Grotenhermen (2000-2003)
Raphael Mechoulam (2003-2005)
Roger Pertwee (2005-2007)